Trial Details

TERMINATED
Basic Information
Clinical ID c4455
Identifier NCT00495521
Trial Title High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn's Disease
Interventions DRUG: 4-Aminosalicylic acid extended release granules
Participant Information
Sponsor Jacobus Pharmaceutical
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2007-06
Primary Completion Date 2008-07
Completion Date 2008-10